US Patent Issued to Iterum Therapeutics International on Feb. 10 for "Combinations of beta-lactam compounds and probenecid and uses thereof" (Irish, American Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,337, issued on Feb. 10, was assigned to Iterum Therapeutics International Ltd. (Dublin).

"Combinations of beta-lactam compounds and probenecid and uses thereof" was invented by Michael Dunne (Old Saybrook, Conn.), Tom Loughman (Dublin) and Aaron Cameron (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to bilayer tablets comprising a second layer comprising a Beta-lactam compound or a pharmaceutically acceptable salt thereof; and a first layer comprising probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease using the bilayer tab...